229 results on '"D'Amico, A.V."'
Search Results
2. Association Between Treatment Modality and Probability of Second Malignancy in Localized Prostate Cancer Patients
3. Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity Following Prostate SBRT: A Combined Analysis of 23 Prospective Clinical Trials
4. Clinical and Dosimetric Outcomes of MR Guided Prostate SBRT With Daily Online Plan Adaptation
5. PSA failure following definitive treatment of Prostrate cancer having Biopsy Gleason score 7 with tertiary grade 5
6. PSA Failure as a Surrogate for All-Cause Mortality in Men with Locally Advanced Prostate Cancer
7. Comorbidity-based Racial Disparities in Prostate Cancer: The Case for Effect Modification
8. Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer
9. Combined External Beam Radiation Therapy and Brachytherapy Versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer
10. Virtual PSA Monitoring Program Pilot: The Integration of Technology in Post Treatment Prostate Cancer Patient Care to Optimize Workflow and Increase Access to Care
11. TRANSPERINEAL MAGNETIC RESONANCE IMAGE GUIDED PROSTATE BIOPSY
12. Germline BRCA2 Mutations in Men With Prostate Cancer Assort into Functional Cluster Regions
13. In Situ Radiosensitization of Brachytherapy: Image Guided Planned Biologic Enhancement of Brachytherapy
14. Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer
15. BRCA2 Mutations in Prostate Cancer Assort Into Cluster Regions
16. Duration of the Anti-Androgen in Men Undergoing 6 Months of an LHRH Agonist and Radiation Therapy for Unfavorable-Risk Prostate Cancer and the Risk of Death
17. Androgen Deprivation Therapy Use in the Setting of High-Dose Radiation Therapy and the Risk of Prostate Cancer–Specific Mortality Stratified by the Extent of Competing Mortality
18. Docetaxel-Loaded Brachytherapy Spacers for Combined Chemoradiation Therapy in Prostate Cancer
19. Whole-Pelvis Versus Prostate-Only Radiation Therapy and Androgen Deprivation Therapy: Effects on Mortality Risk
20. Risk Group and Death From Prostate Cancer Among Men Undergoing Brachytherapy
21. Location of Local Recurrence After MRI-Guided Partial Prostate Brachytherapy Targeting Only the Peripheral Zone: Implications for Focal Therapy
22. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
23. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion
24. Incidence and determinants of 1-month mortality after cancer-directed surgery
25. The Impact of Race on Prostate-Cancer Specific Mortality Among Men With Low-Risk Disease: Potential Implications for Active Surveillance
26. Association of Androgen Deprivation Therapy with Excess Cardiovascular-Specific Mortality in Men with Prostate Cancer
27. Racial Disparities in the Management of African American Men With Intermediate- to High-Risk Prostate Cancer
28. Defining the Optimal Approach to the Patient With Postradiation Prostate-Specific Antigen Recurrence Using Outcome Data From a Prospective Randomized Trial
29. Feasibility of transperineal prostate biopsy under interventional Magnetic Resonance guidance
30. Identification of Comorbidities That Place Men at Highest Risk of Harm From Androgen Deprivation Therapy for Prostate Cancer
31. Preoperative 3-Tesla Multiparametric Endorectal MRI Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer
32. Locally Drug Enhanced Brachytherapy: A Comparison of 2 Approaches Based on Biologically Effective Dose
33. Balancing Competing Risks of Recurrence and Death from High-risk Prostate Cancer Versus Cardiovascular Mortality in Men Treated With Hormonal Therapy: A Decision Analysis
34. Advancing Age Within Established Gleason Score Categories and the Risk of Prostate Cancer-specific Mortality
35. Metachronous Cancer Diagnosis in Men With Prostate Cancer and the Risk of Prostate Cancer-specific Mortality: A Competing Risks Analysis
36. Physician Bias, Referral to a Medical Oncologist, and Active Surveillance in Low-risk Prostate Cancer
37. Post-Treatment Prostate-Specific Antigen Nadir is Predictive of All-Cause Mortality: A Reanalysis of the Dana Farber Cancer Institute Radiation With or Without Androgen Deprivation Therapy Randomized Trial
38. The Impact of Genetic Variants in the Double-Stranded DNA Break Repair Pathway on Cancer Control in Men Treated with Radiation for Prostate Cancer
39. The Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
40. The Number of High-Risk Factors and the Risk of Prostate Cancer-Specific Mortality Following Radical Prostatectomy or Brachytherapy
41. Predictors of the Use of Supplemental Androgen Suppression Therapy (AST) and External Beam Radiation Therapy (EBRT) in Men with High-risk Prostate Cancer (PC) Undergoing Brachytherapy
42. Whole Pelvis vs. Prostate Only Irradiation and Mortality in Men with Prostate Cancer Treated with or without Hormonal Therapy
43. Tomosynthesis for Setup of Prostate Patients Treated with Rectal Balloon Immobilization
44. The Adverse Impact of Androgen Deprivation Therapy on All-cause Mortality in Men with High-risk Prostate Cancer and a History of Congestive Heart Failure (CHF) or Myocardial Infarction (MI)
45. Patient-reported Quality of Life (QOL) in Unfavorable-Risk Prostate Cancer: Sexual Function Recovery after External Beam Radiation (RT) and 6 months of Androgen Deprivation
46. Salvage Radiation in Men with PSA Failure following Radical Prostatectomy and the Risk of Death
47. Aspirin Use and the Risk of Prostate Cancer Death in Men Treated with Prostatectomy or Radiotherapy: Results from the CaPSURE Database
48. Hormonal Therapy or External Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer
49. Cardiac Comorbidity and Mortality in Men with Prostate Cancer Treated with Brachytherapy with or without Neoadjuvant Hormonal Therapy
50. The use of Postprostatectomy Radiation Therapy in the United States: Patterns of Care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.